Biotech News
Glox Therapeutics Receives Share of £3M CF AMR Syndicate Fund to Combat Lung Infections
Glox Therapeutics, a company specialising in precision antibiotic therapies, has secured up to £500,000 in funding from the Collaborative Discovery Programme (CDP). The CDP, launched by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate with backing from the medical research
22 January 2025